In brief: Burns joins Progen; Cryptome appoints CSO
Monday, 23 August, 2004
Progen Industries (ASX: PGL, NASDAQ: PGLAF), announced today it had appointed former Bresagen chief financial officer and company secretary, Linton Burns, as CFO and company secretary.
Burns succeeds Milton McColl, has been Progen's CFO since late 2001.
And Melbourne-based Cryptome Pharmaceuticals (ASX: CRP) has appointed Dr Leodevico Ilag as chief scientific officer. Dr Ilag is the co-founder, former managing director and current chief technology officer of Munich proteomics company Xerion Pharmaceuticals. He is due to join Cryptome in September 2004.
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
